Making USP Guidance Actionable For CGT Materials

In this segment of Cell & Gene Live, Anthony Blaszczyk, Ph.D., Senior Scientist at the U.S. Pharmacopeia, and Basak Clements, Ph.D., Founder and Senior Advisor at biomatria, were joined by Cell & Gene Chief Editor Erin Harris to discuss USP’s Cell & Gene Therapy Expert Committee, which is working to make existing guidance, such as USP 1043, more practical and actionable, while developing updated frameworks that clarify roles across the supply chain and strengthen risk-based control of raw materials.